- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
TissueGene Inc (950160)
Assess today's live TissueGene Inc (950160) share price, performance and insights using our live KOSDAQ: 950160 stock exchange data.
Analyse the historical data and TissueGene Inc share price performance charts on this page. Our technical summary section provides analysis on TissueGene share price buy/sell indicators using real-time data (or discuss the TissueGene (950160) stock price today with other investors in the TissueGene KQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current KQ 950160 share price (ISIN: KR8840120008) to enhance your trading decisions with our free investment tools and resources.
What Is the TissueGene Inc Share Price Today?
The TissueGene share price today is 102,300.
What Is the Stock Symbol for TissueGene Inc
The stock symbol (or 'ticker') for TissueGene Inc is "950160."
What Stock Exchange Does TissueGene Inc Trade On?
TissueGene Inc is listed and trades on the KOSDAQ stock exchange.
Is TissueGene Inc a Good Stock to Buy?
Determining whether TissueGene Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and TissueGene Inc share price performance charts on this page. Our technical summary section provides analysis on TissueGene share price buy/sell indicators using real-time data (or discuss the TissueGene (950160) stock price today with other investors in the TissueGene KQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current KQ 950160 share price (ISIN: KR8840120008) to enhance your trading decisions with our free investment tools and resources.
What Is the TissueGene Inc Share Price Today?
The TissueGene share price today is 102,300.
What Is the Stock Symbol for TissueGene Inc
The stock symbol (or 'ticker') for TissueGene Inc is "950160."
What Stock Exchange Does TissueGene Inc Trade On?
TissueGene Inc is listed and trades on the KOSDAQ stock exchange.
Is TissueGene Inc a Good Stock to Buy?
Determining whether TissueGene Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
KOSDAQ
Currency in KRW
102,300
0(0.00%)
Delayed Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
98,500
107,400
52 wk Range
31,250
112,800
950160 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
98,500107,400
52 wk Range
31,250112,800
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
950160 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
150,000
Upside
+46.63%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock price often moves in the opposite direction of the market
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Buy
Moving Averages
Buy
TissueGene Company Profile
Kolon TissueGene, Inc. develops cell therapies for orthopedic diseases and other unmet medical needs. The company’s lead product is the TG-C that has completed Phase II trials to treat osteoarthritis, as well as rheumatoid arthritis, meniscus, and spinal discs. It is also developing cell therapies for musculoskeletal system disorders, as well as vet medicine. Kolon TissueGene, Inc. was formerly known as TissueGene, Inc. and changed its name to Kolon TissueGene, Inc. in March 2018. The company was founded in 1999 and is headquartered in Rockville, Maryland.
Compare 950160 to Peers and Sector
Metrics to compare | 950160 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship950160PeersSector | |
|---|---|---|---|---|
P/E Ratio | −91.6x | −9.7x | −0.5x | |
PEG Ratio | 0.28 | −0.24 | 0.00 | |
Price/Book | 43.5x | 3.6x | 2.6x | |
Price / LTM Sales | 1,578.6x | 27.1x | 3.2x | |
Upside (Analyst Target) | 55.8% | 68.5% | 51.3% | |
Fair Value Upside | Unlock | 10.8% | 8.9% | Unlock |
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 150,000
(+46.63% Upside)
Earnings
Latest Release
Nov 14, 2025
EPS / Forecast
-76.20 / --
Revenue / Forecast
1.72B / --
People Also Watch
FAQ
What Is the TissueGene (950160) Share Price Today?
The TissueGene stock price today is 102,300 KRW.
What Stock Exchange Does TissueGene (950160) Trade On?
TissueGene is listed and trades on the KOSDAQ.
What Is the Ticker (Stock Symbol) for TissueGene?
The stock symbol (also called a 'ticker') for TissueGene is "950160."
What Is the Current TissueGene Market Cap?
As of today, TissueGene market cap is 8.52T KRW.
What Is TissueGene's (950160) Earnings Per Share (TTM)?
The TissueGene EPS is currently -1,075 (Trailing Twelve Months).
Is 950160 a Buy or Sell From a Technical Analyst Perspective?
Based on today's TissueGene moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has TissueGene Stock Split?
TissueGene has split 0 times. (See the 950160 stock split history page for full effective split date and price information.)
What is the current trading status of TissueGene (950160)?
As of 06/03/2026, TissueGene (950160) is trading at a price of 102,300 KRW, with a previous close of 102,300 KRW. The stock has fluctuated within a day range of 98,500 KRW to 107,400 KRW, while its 52-week range spans from 31,250 KRW to 112,800 KRW.
What Is TissueGene (950160) Price Target According to Analysts?
The average 12-month price target for TissueGene is 150,000 KRW, with a high estimate of 150000 KRW and a low estimate of 150000 KRW. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +46.63% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.